skip to the content

Media Releases

19 Jan 2011    
A partnership between the University of Auckland Business School and pharmaceutical company Roche is providing the opportunity for an Economics graduate to gain real world experience of the corporate world, whilst applying economics research techniques in a health policy setting.  Read More    
 
19 Jan 2011    
The Wellington Regional Rheumatology Trust has organised a summer studentship through sponsorship by pharmaceutical company Roche.  Read More    
 
03 Sep 2010    

New Zealanders fighting the country’s leading cause of cancer death will benefit following PHARMAC’s announcement today of their decision to fund Roche’s Tarceva® (erlotinib), a treatment that extends survival and improves quality of life for advanced lung cancer sufferers  Read More

   
17 Jun 2009    
New Zealanders diagnosed with indolent (low grade) non Hodgkin’s lymphoma (NHL) now have expanded funding for a cutting edge biotherapy, MabThera® (rituximab), increasing their chances of beating this slowly progressing but often fatal disease.  Read More    
 
19 May 2009    
Widened access to a leading-edge biotherapy has given hope to hundreds of New Zealanders diagnosed with chronic lymphocytic leukaemia (CLL), a stubbornly incurable form of white blood cell cancer. Read More    
 

Publications

From time to time, Roche publishes articles and policy papers on key issues related to our products, the therapeutic areas we operate in and the health sector in general.  Where appropriate, we will make these publications available.  If you are aware of a Roche authored article or paper that you would like to obtain a copy of, please use our Contact link at the top of this page.

Access to Innovative Treatments RA Executive Summary
Access to Innovative Treatments RA Final
The introduction of Biosimilars to New Zealand health system

Media Enquiries

For all media enquiries please phone or email your enquiry using our Contacts page.

Contact